OTC Products - Albania

Albania

The OTC Products market in Albania is projected to reach revenue of US$212.10m in 2024.
It is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 4.88%, leading to a market volume of US$269.20m by 2029.
Among countries worldwide, China is anticipated to generate the highest revenue of US$74.91bn in 2024.
When considering the total population, the per person revenues in Albania are estimated to be US$75.06 in 2024.
"Albania has seen a surge in demand for OTC products, driven by increasing healthcare awareness and a growing middle class."

Key regions: Europe, Australia, United Kingdom, Germany, South Korea

Market

Region

Region comparison

Currency

Analyst Opinion

The OTC Products (Pharmacies) market in Albania is experiencing significant growth and development.

Customer preferences: Albanian consumers have shown a growing preference for OTC products in recent years. This can be attributed to several factors, including increasing health awareness, a desire for self-care, and the convenience of purchasing medication without a prescription. Additionally, the affordability of OTC products compared to prescription drugs has also contributed to their popularity among consumers.

Trends in the market: One key trend in the OTC Products (Pharmacies) market in Albania is the increasing availability and variety of products. Pharmacies are expanding their product offerings to cater to the diverse needs of consumers. This includes a wide range of OTC medications, vitamins and supplements, personal care products, and health devices. The market is also witnessing a rise in the availability of natural and herbal remedies, as consumers are increasingly seeking alternative healthcare options. Another trend in the market is the growing presence of online pharmacies. With the advancement of technology and the increasing use of smartphones, consumers are turning to online platforms to purchase OTC products. This trend has been further accelerated by the COVID-19 pandemic, which has led to an increase in online shopping across various sectors, including healthcare. Online pharmacies offer convenience, competitive pricing, and home delivery services, making them an attractive option for consumers.

Local special circumstances: Albania's healthcare system has undergone significant reforms in recent years, which have positively impacted the OTC Products (Pharmacies) market. The government has implemented policies to improve access to healthcare services and promote self-care. This has led to an increased emphasis on OTC products as a means of managing minor ailments and reducing the burden on healthcare facilities. Furthermore, the Albanian population is aging, which has created a growing demand for OTC products. As individuals age, they tend to require more medication for chronic conditions and general health maintenance. This demographic shift has fueled the demand for OTC products, as older consumers seek accessible and affordable healthcare solutions.

Underlying macroeconomic factors: Albania's improving economic conditions have also contributed to the development of the OTC Products (Pharmacies) market. Rising disposable incomes and a growing middle class have increased consumers' purchasing power, enabling them to spend more on healthcare products. Additionally, the country's integration into the European Union has facilitated the import and distribution of a wider range of OTC products, further driving market growth. In conclusion, the OTC Products (Pharmacies) market in Albania is experiencing significant growth and development due to changing customer preferences, increasing availability of products, the rise of online pharmacies, local special circumstances, and underlying macroeconomic factors. As the market continues to evolve, it is expected to offer new opportunities for both local and international players in the healthcare industry.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.